No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:16617600-16619000 |
Enhancers |
Right Atrium |
heart
|
2 |
chr5:16617800-16619200 |
Weak transcription |
Pancreatic Islets |
Pancreatic Islet
|
3 |
chr5:16617800-16619400 |
Enhancers |
Fetal Thymus |
thymus
|
4 |
chr5:16617800-16621600 |
Weak transcription |
Left Ventricle |
heart
|
5 |
chr5:16617800-16625800 |
Weak transcription |
Brain Anterior Caudate |
brain
|
6 |
chr5:16618000-16619000 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
7 |
chr5:16618000-16619000 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
8 |
chr5:16618000-16619200 |
Enhancers |
Primary T helper memory cells from peripheral blood 2 |
blood
|
9 |
chr5:16618000-16619200 |
Enhancers |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
10 |
chr5:16618000-16619200 |
Weak transcription |
Cortex derived primary cultured neurospheres |
brain
|
11 |
chr5:16618000-16619600 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
12 |
chr5:16618000-16623200 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
13 |
chr5:16618200-16619000 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
14 |
chr5:16618200-16619000 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
15 |
chr5:16618200-16619000 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
16 |
chr5:16618200-16619200 |
Weak transcription |
Brain Cingulate Gyrus |
brain
|
17 |
chr5:16618200-16619600 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
18 |
chr5:16618200-16619800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
19 |
chr5:16618400-16619400 |
Enhancers |
Primary T cells fromperipheralblood |
blood
|
20 |
chr5:16618400-16619400 |
Enhancers |
Fetal Intestine Small |
intestine
|
21 |
chr5:16618400-16619800 |
Enhancers |
Primary T killer memory cells from peripheral blood |
blood
|
22 |
chr5:16618400-16620000 |
Enhancers |
Primary T helper cells fromperipheralblood |
blood
|
23 |
chr5:16618400-16620200 |
Enhancers |
Primary T cells from cord blood |
blood
|
24 |
chr5:16618600-16619000 |
Weak transcription |
Fetal Kidney |
kidney
|
25 |
chr5:16618600-16619200 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
26 |
chr5:16618600-16619200 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
27 |
chr5:16618600-16619800 |
Enhancers |
Primary T killer naive cells fromperipheralblood |
blood
|
28 |
chr5:16618600-16619800 |
Enhancers |
Thymus |
Thymus
|
29 |
chr5:16618600-16626200 |
Weak transcription |
Primary mononuclear cells fromperipheralblood |
Blood
|
30 |
chr5:16618600-16627000 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
31 |
chr5:16618800-16619000 |
Enhancers |
Primary T helper naive cells from peripheral blood |
blood
|
32 |
chr5:16618800-16619400 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
33 |
chr5:16618800-16620400 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
34 |
chr5:16618800-16621000 |
Enhancers |
Primary T helper naive cells fromperipheralblood |
blood
|
35 |
chr5:16618800-16621400 |
Weak transcription |
Fetal Heart |
heart
|